Partnering with ArchiMed helped us develop high-impact solutions to solve our business challenges. Medistream benefited both from ArchiMed’s international network of talent and from the board level support it brings as a health-industry insider. ArchiMed is a fund designed to specifically invest in small and medium sized companies – this mindset is what sets them apart from other private equity firms in the health industry landscape. We’ve found in ArchiMed a partner for whom whom regular and transparent conversations are fundamental to building a strong company.
We are excited to work in partnership with ArchiMed and leverage their networks in both the consulting and healthcare industries to help take Deallus into the next phase of its growth. With Archimed’s support, we will look to further extend our global footprint and grow our service offering as we continue to develop innovative approaches to help our clients address competitive challenges in an increasingly complex healthcare environment
I have worked with a number of private equity funds over my career and am well placed to benchmark ArchiMed. Whilst a relatively new fund the ArchiMed team are clearly experienced and well connected in the Healthcare sector and such specialist knowledge will be a benefit to me and the business going forward. In structuring the deal they have been pragmatic in considering management legacy and rolled positions, balancing this with a need to incentivise any new management subsequently brought in as well as the obvious investor requirements. Operationally, they have taken a keen interest in strategy and market approach seeking to balance both organic and acquisitive initiatives but ensuring that the executive management team retain ownership of direction and delivery.
Archimed is helping us grow in terms of professionalisation. Archimed in not just a financial partner, it's an industrial partner. In the health market it's so important to focus not only on the numbers like EBITDA, but also focus on the quality of the service and of the treatment that we have to deliver to people. So we are partners not only for economic reasons but also in the soul. We’ve found in ArchiMed a partner for whom regular and transparent conversations are fundamental to building a strong company.